MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • MDS Virtual Congress 2020

    Serum neurofilament light chain differentiates early Parkinson’s disease from progressive supranuclear palsy-parkinsonism

    R. Yadav, P. Ramaswamy, P. Pal, R. Christopher (Bengaluru, India)

    Objective: To assess the value of serum neurofilament light chain (NFL) levels in differentiating parkinsonian syndromes. Background: The diagnosis of Parkinson’s disease (PD) mostly relies…
  • MDS Virtual Congress 2020

    Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy

    E. Bayram, J. Jankovic, S. Reich, C. Marras, Y. Bordelon, D. Shprecher, R. Dubinsky, I. Litvan (La Jolla, CA, USA)

    Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…
  • MDS Virtual Congress 2020

    Inertial sensor-based kinematics in the differential diagnosis of Parkinson’s disease and atypical parkinsonisms

    M. Mendonça, P. Ferreira, R. Barbosa, B. Meira, J. da Silva, R. Costa, R. Matias (Lisboa, Portugal)

    Objective: Assess the role of inertial sensors in the phenotyping and differential diagnosis of Parkinson’s Disease vs. Atypical Parkinsonisms Background: Wearable devices have been used…
  • MDS Virtual Congress 2020

    Midbrain/pons area ratio and clinical features predict the prognosis of Progressive Supranuclear Palsy

    S-S. Cui, Y-Y. Tan, S.D Chen (Shanghai, China)

    Objective: This retrospective study aims to characterize the natural history of PSP and to find predictors of shorter survival and faster decline of activity of…
  • MDS Virtual Congress 2020

    Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

    M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)

    Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…
  • 2019 International Congress

    The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers

    T. Xie, X. Ye, J. de Courcy, K. Golden, Y. Bao, J. Zamudio, L. Chiodo, J. Morgan (Mettawa, IL, USA)

    Objective: To quantify the impact of varying severity levels on caregivers’ burden and health-related quality of life (HRQoL). Background: PSP is a progressive disease. Patients…
  • 2019 International Congress

    Ocular Motor Dysfunction as the Predictable Milestone of Life Prognosis in Progressive Supranuclear Palsy

    T. Ishihara, T. Oeda, S. Tomita, A. Umemura, M. Kohsaka, K. Park, M. Tahara, K. Yamamoto, H. Sawada (Kyoto, Japan)

    Objective: The purpose of this study was to identify which symptoms predict the life prognosis in progressive supranuclear palsy (PSP). Background: Patients with PSP are…
  • 2019 International Congress

    Aberrant structural connectivity of the executive network in Progressive Supranuclear Palsy

    S. Prasad, A. Rajan, S. Mangalore, J. Saini, M. Ingalhalikar, P. Pal (Bangalore, India)

    Objective: To ascertain the structural connectivity of the executive network in progressive supranuclear palsy (PSP) using probabilistic tractography. Background: Cognitive deficits are highly prevalent in…
  • 2019 International Congress

    White matter abnormalities correlate with clinical features in PSP patients

    A. Campabadal, A. Abos, B. Segura, HC. Baggio, C. Uribe, A. Garrido, A. Camara, E. Muñoz, F. Valldeoriola, MJ. Martí, C. Junqué, Y. Compta (Barcelona, Spain)

    Objective: To detect white matter abnormalities in PSP patients and their correlation with motor and cognitive impairment. Background: Progressive Supranuclear Palsy (PSP) is a tauopathy…
  • 2019 International Congress

    Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study

    H. Soares, Z. Jin, N. Fisseha, M. Gold, C. Locke, B. Rendenbach-Mueller, E. Smith, I. Suridjan, A. Vasanthakumar, N. Mendonca (Ludwigshafen, Germany)

    Objective: To characterize the genetic and biomarker profile of patients with Progressive Supranuclear Palsy (PSP) and the relationship of potential biomarkers with baseline disease severity.…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley